Co-founder of Red Glead Discovery – a pre-clinical drug discovery CRO. Thomas Brimert is a skilled organic and medicinal chemist with over 20 years of experience. After a post-doc at the University of Odense in Denmark, he joined AstraZeneca R&D Lund as a Senior Research Scientist (2000-2011). Since 2011 he has had leading roles at Red Glead Discovery. He has contributed to successful deliveries of clinical candidates both at AstraZeneca and Red Glead Discovery.
